Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparing Diabetes Prevention Programs

This study has been completed.
Information provided by (Responsible Party):
Nancy Bennett, University of Rochester Identifier:
First received: August 2, 2011
Last updated: January 15, 2016
Last verified: January 2016
The purpose of this study is to compare the effectiveness and costs of two programs,the Diabetes Prevention Program and the community-developed Healthy Living Program, delivered in an primary care practice.

Condition Intervention
Pre Diabetes
Behavioral: Diabetes Prevention Program
Behavioral: Healthy Living Program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Comparative Effectiveness of Practice-Based Diabetes Prevention Programs - A Pilot Study

Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • Participant Weight [ Time Frame: 22 weeks ] [ Designated as safety issue: No ]
    7% reduction in participant weight

Secondary Outcome Measures:
  • Minutes of Physical Activity [ Time Frame: 22 weeks ] [ Designated as safety issue: No ]
    Increase physical activity to 150 minutes per week.

Enrollment: 92
Study Start Date: May 2011
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Diabetes Prevetion Program
Individuals in this group will receive the Diabetes Prevention Program
Behavioral: Diabetes Prevention Program
Other Name: DPP
Active Comparator: Healthy Living Program
Individuals in this group will receive the Healthy Living Program
Behavioral: Healthy Living Program
Other Name: HLP


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • at least 18 years old
  • diagnosed with pre-diabetes

Exclusion Criteria:

  • diagnosed with diabetes
  • pregnant or nursing
  • unable to walk 2-3 blocks in 10 minutes
  • unable to read and speak English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01409889

United States, New York
Anthony Jordan Health Center
Rochester, New York, United States, 14605
Rochester General Medical Associates
Rochester, New York, United States, 14605
Unity Health System
Rochester, New York, United States, 14606
Westside Health Services
Rochester, New York, United States, 14611
Sponsors and Collaborators
University of Rochester
  More Information

Responsible Party: Nancy Bennett, Professor, University of Rochester Identifier: NCT01409889     History of Changes
Other Study ID Numbers: CTSI 5-27805 
Study First Received: August 2, 2011
Last Updated: January 15, 2016
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus
Prediabetic State
Glucose Intolerance
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hyperglycemia processed this record on October 25, 2016